| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$75,929 |
|
|
|
Indirect Value
|
$34,834,505 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$34,910,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-09-19 |
4 |
AS |
$35.02 |
$1,753,080 |
D/D |
(50,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2013-09-20 |
4 |
AS |
$35.90 |
$313,749 |
D/D |
(8,740) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-01-02 |
4 |
AS |
$39.25 |
$1,141,325 |
D/D |
(29,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-01-02 |
4 |
AS |
$39.25 |
$98,133 |
I/I |
(2,500) |
174 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-01-08 |
4 |
AS |
$40.05 |
$440,572 |
D/D |
(11,000) |
1,661 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-01-08 |
4 |
AS |
$40.05 |
$60,078 |
I/I |
(1,500) |
174 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-04-02 |
4 |
AS |
$43.65 |
$78,566 |
I/I |
(1,800) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-04-02 |
4 |
AS |
$43.65 |
$305,536 |
D/D |
(7,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-06-10 |
4 |
AS |
$33.46 |
$33,455 |
I/I |
(1,000) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-06-10 |
4 |
AS |
$33.46 |
$334,550 |
D/D |
(10,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-06-19 |
4 |
AS |
$35.10 |
$386,111 |
D/D |
(11,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-07-01 |
4 |
AS |
$35.55 |
$71,100 |
I/I |
(2,000) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-07-01 |
4 |
AS |
$35.58 |
$551,459 |
D/D |
(15,500) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-08-01 |
4 |
AS |
$30.53 |
$457,875 |
D/D |
(15,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-08-01 |
4 |
AS |
$30.53 |
$30,525 |
I/I |
(1,000) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-08-13 |
4 |
AS |
$35.45 |
$549,537 |
D/D |
(15,500) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman, President and CEO |
• • – |
2014-08-13 |
4 |
AS |
$35.45 |
$56,726 |
I/I |
(1,600) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-10-01 |
4 |
AS |
$37.91 |
$75,822 |
I/I |
(2,000) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-10-01 |
4 |
AS |
$37.91 |
$758,220 |
D/D |
(20,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-10-03 |
4 |
AS |
$39.49 |
$513,331 |
D/D |
(13,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-10-03 |
4 |
AS |
$39.49 |
$39,487 |
I/I |
(1,000) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-10-23 |
4 |
AS |
$42.22 |
$67,552 |
I/I |
(1,600) |
627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2014-10-23 |
4 |
AS |
$42.22 |
$548,860 |
D/D |
(13,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2015-01-06 |
4 |
AS |
$66.04 |
$660,380 |
D/D |
(10,000) |
6,941 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2015-01-06 |
4 |
AS |
$66.04 |
$66,038 |
I/I |
(1,000) |
627 |
0 |
- |
|
463 Records found
|
|
Page 5 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
